KIRSTY (insulin aspart-xjhz)
KIRSTY (insulin aspart-xjhz) is a rapid-acting human insulin analog. It is indicated to improve glycemic control in both adult and pediatric patients diagnosed with diabetes mellitus. The drug serves as a therapeutic intervention for managing blood sugar levels in these patient populations.
How KIRSTY Works
KIRSTY regulates glucose metabolism by lowering blood glucose through the stimulation of peripheral glucose uptake, specifically in skeletal muscle and fat. It further reduces blood sugar levels by inhibiting the production of glucose within the liver. Additionally, the drug inhibits the breakdown of fats and proteins while enhancing protein synthesis.
Details
- Status
- Prescription
- First Approved
- 2025-07-15
- Routes
- SOLUTION
- Dosage Forms
- INJECTION
KIRSTY Approval History
What KIRSTY Treats
1 indicationsKIRSTY is approved for 1 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Diabetes
Pharmacists can substitute KIRSTY for Fiasp without calling the prescriber. This is a lower-cost alternative with no clinically meaningful differences.
KIRSTY Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in KIRSTY's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications KIRSTY treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to KIRSTY
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
KIRSTY FDA Label Details
Indications & Usage
FDA Label (PDF)KIRSTY is indicated for the treatment of Diabetes.
Track KIRSTY with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.